Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 161

Similar articles for PubMed (Select 23361338)

1.

Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors.

Villaseñor A, Ballard-Barbash R, Ambs A, Bernstein L, Baumgartner K, Baumgartner R, Ulrich CM, Hollis BW, McTiernan A, Neuhouser ML.

Cancer Causes Control. 2013 Apr;24(4):759-67. doi: 10.1007/s10552-013-0158-4. Epub 2013 Jan 30.

2.

Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors.

Neuhouser ML, Sorensen B, Hollis BW, Ambs A, Ulrich CM, McTiernan A, Bernstein L, Wayne S, Gilliland F, Baumgartner K, Baumgartner R, Ballard-Barbash R.

Am J Clin Nutr. 2008 Jul;88(1):133-9.

3.

Dietary fiber, carbohydrates, glycemic index, and glycemic load in relation to breast cancer prognosis in the HEAL cohort.

Belle FN, Kampman E, McTiernan A, Bernstein L, Baumgartner K, Baumgartner R, Ambs A, Ballard-Barbash R, Neuhouser ML.

Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):890-9. doi: 10.1158/1055-9965.EPI-10-1278. Epub 2011 Mar 23.

4.

Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?

Vrieling A, Seibold P, Johnson TS, Heinz J, Obi N, Kaaks R, Flesch-Janys D, Chang-Claude J.

Int J Cancer. 2014 Jun 15;134(12):2972-83. doi: 10.1002/ijc.28628. Epub 2013 Dec 7.

PMID:
24272459
5.

Serum vitamin D and breast density in breast cancer survivors.

Neuhouser ML, Bernstein L, Hollis BW, Xiao L, Ambs A, Baumgartner K, Baumgartner R, McTiernan A, Ballard-Barbash R.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):412-7. doi: 10.1158/1055-9965.EPI-09-0774. Epub 2010 Jan 19.

6.

Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study.

Vrieling A, Hein R, Abbas S, Schneeweiss A, Flesch-Janys D, Chang-Claude J.

Breast Cancer Res. 2011 Jul 26;13(4):R74. doi: 10.1186/bcr2920.

7.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

8.

Serum 25-hydroxyvitamin D, vitamin A, and lung cancer mortality in the US population: a potential nutrient-nutrient interaction.

Cheng TY, Neuhouser ML.

Cancer Causes Control. 2012 Sep;23(9):1557-65. doi: 10.1007/s10552-012-0033-8. Epub 2012 Jul 25.

PMID:
22829430
9.

Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women.

Fedirko V, Torres-Mejía G, Ortega-Olvera C, Biessy C, Angeles-Llerenas A, Lazcano-Ponce E, Saldaña-Quiroz VA, Romieu I.

Cancer Causes Control. 2012 Jul;23(7):1149-62. doi: 10.1007/s10552-012-9984-z. Epub 2012 May 24.

PMID:
22622862
10.

Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer.

Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N.

J Clin Oncol. 2009 Aug 10;27(23):3757-63. doi: 10.1200/JCO.2008.20.0725. Epub 2009 May 18.

11.

Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study.

Villaseñor A, Ballard-Barbash R, Baumgartner K, Baumgartner R, Bernstein L, McTiernan A, Neuhouser ML.

J Cancer Surviv. 2012 Dec;6(4):398-406. doi: 10.1007/s11764-012-0234-x. Epub 2012 Oct 4.

12.

Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study.

Schöttker B, Haug U, Schomburg L, Köhrle J, Perna L, Müller H, Holleczek B, Brenner H.

Am J Clin Nutr. 2013 Apr;97(4):782-93. doi: 10.3945/ajcn.112.047712. Epub 2013 Feb 27.

13.

The association between television watching time and all-cause mortality after breast cancer.

George SM, Smith AW, Alfano CM, Bowles HR, Irwin ML, McTiernan A, Bernstein L, Baumgartner KB, Ballard-Barbash R.

J Cancer Surviv. 2013 Jun;7(2):247-52. doi: 10.1007/s11764-013-0265-y. Epub 2013 Feb 2.

14.

Risk factors for self-reported arm lymphedema among female breast cancer survivors: a prospective cohort study.

Togawa K, Ma H, Sullivan-Halley J, Neuhouser ML, Imayama I, Baumgartner KB, Smith AW, Alfano CM, McTiernan A, Ballard-Barbash R, Bernstein L.

Breast Cancer Res. 2014 Aug 22;16(4):414. doi: 10.1186/s13058-014-0414-x.

15.

Change in peripheral blood leukocyte telomere length and mortality in breast cancer survivors.

Duggan C, Risques R, Alfano C, Prunkard D, Imayama I, Holte S, Baumgartner K, Baumgartner R, Bernstein L, Ballard-Barbash R, Rabinovitch P, McTiernan A.

J Natl Cancer Inst. 2014 Apr;106(4):dju035. doi: 10.1093/jnci/dju035. Epub 2014 Mar 13.

16.

Circulating levels of 25-hydroxyvitamin D and prostate cancer prognosis.

Holt SK, Kolb S, Fu R, Horst R, Feng Z, Stanford JL.

Cancer Epidemiol. 2013 Oct;37(5):666-70. doi: 10.1016/j.canep.2013.07.005. Epub 2013 Aug 20.

17.

Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort.

McCullough ML, Stevens VL, Patel R, Jacobs EJ, Bain EB, Horst RL, Gapstur SM, Thun MJ, Calle EE.

Breast Cancer Res. 2009;11(4):R64. doi: 10.1186/bcr2356. Epub 2009 Aug 28.

18.

Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: a nested case-control study in the multiethnic cohort study.

Kim Y, Franke AA, Shvetsov YB, Wilkens LR, Cooney RV, Lurie G, Maskarinec G, Hernandez BY, Le Marchand L, Henderson BE, Kolonel LN, Goodman MT.

BMC Cancer. 2014 Jan 17;14:29. doi: 10.1186/1471-2407-14-29.

19.

Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) Study.

Jacobs ET, Thomson CA, Flatt SW, Al-Delaimy WK, Hibler EA, Jones LA, Leroy EC, Newman VA, Parker BA, Rock CL, Pierce JP.

Am J Clin Nutr. 2011 Jan;93(1):108-17. doi: 10.3945/ajcn.2010.30009. Epub 2010 Oct 27.

20.

Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease.

Grandi NC, Breitling LP, Vossen CY, Hahmann H, Wüsten B, März W, Rothenbacher D, Brenner H.

Am Heart J. 2010 Jun;159(6):1044-51. doi: 10.1016/j.ahj.2010.03.031.

PMID:
20569718
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk